DIA Daily关注“DIA发布”DailyBreaking News Just for DIA Members！Nov,14,2022Leading the NewsModerna, Pfizer Launch Trials On Potential Long-Term Impacts Of COVID-19 Vaccine-Associated MyocarditisNBC News (11/12,Lovelace) reported the “research in the U.S. is underway, tracking adverse health effects – if any – that may appear in the years following a diagnosis of” COVID-19 “vaccine-associated heart problems,” specifically myocarditis or pericarditis. Moderna has “launched two trials, the most recent in September,” and “Pfizer confirmed that at least one of its trials, which will include up to 500 teens and young adults under age 21, is slated to begin in the next couple of months.” Early data “could be published as early as next year, sources told NBC News.”Drug UpdatesFDA Approves AstraZeneca’s Durvalumab, Tremelimumab Plus Chemotherapy For Treatment Of Adults With Stage IV Non-Small Cell Lung CancerReuters (11/11, Karimi) reported AstraZeneca “said
………………………………
